SC
GMAB icon

Syon Capital’s Genmab GMAB Stock Holding History

Syon Capital’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
11,023
+3,123
+40% +$83K 0.01% 795
2026
Q1 		$212K Buy
7,900
+408
+5% +$12.2K 0.01% 865
2025
Q4 		$231K Buy
7,492
+120
+2% +$3.74K 0.01% 828
2025
Q3 		$226K Buy
+7,372
New +$180K 0.01% 752
2023
Q4 		– Sell
-9,414
Closed -$332K – 458
2023
Q3 		$332K Buy
+9,414
New +$359K 0.04% 255

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Syon Capital's GMAB Position: Q2 2026 in Review

Syon Capital increased its Genmab (GMAB) stake by 40% in Q2 2026, buying an estimated $83K and bringing the position to 11,023 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #795.

Syon Capital first reported a position in GMAB in Q3 2023 and has held it in 5 quarters since. The position peaked at $332K in Q3 2023. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Syon Capital held 11,023 shares of Genmab worth $303K as of Q2 2026.
  • Syon Capital bought 3,123 Genmab shares in Q2 2026, an estimated $83K.
  • Genmab made up 0.01% of Syon Capital's portfolio in Q2 2026, its #795 holding.
  • Syon Capital first reported a position in Genmab in Q3 2023 and has held it in 5 quarters since.
  • Syon Capital's Genmab position peaked at $332K in Q3 2023.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.